Maternal compound W serial measurements for the management of fetal hypothyroidsm

European Journal of Endocrinology

Volumn 141, Issue 6, 1999, Pages 570-578

  Cortelazzi, Donatella ^a   Morpurgo, Paola S ^a   Zamperini, Paola ^a   Fisher, Delbert A ^b   Beck Peccoz, Paolo ^a,d   Wu, Sing Yung ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIIODOTHYRONINE; PROPYLTHIOURACIL; THYROTROPIN; TIRATRICOL;

ARTICLE; BLOOD PLACENTA BARRIER; CONGENITAL HYPOTHYROIDISM; DISEASE MARKER; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FREE THYROXINE INDEX; HUMAN; HUMAN EXPERIMENT; MATERNAL SERUM; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

EID: 0033389234     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410570     Document Type: Article

References (44)

1. Wu SY, Polk H, Wong S, Reviczky A, Vu R & Fisher DA. Thyronine sulfate is a major thyroid hormone metabolite and a potential intermediate in the monodeiodination pathways in fetal sheep. Endocrinology 1992 131 1751-1756.
2. Santini F, Cortelazzi D, Baggiani AM, Marconi AM, Beck-Peccoz P & Chopra IJ. A study of the serum 3,5,3′ triiodothyronine sulfate concentration in normal and hypothyroid fetuses at various gestational stages. Journal of Clinical Endocrinology and Metabolism 1993 76 1583-1587.
3. Polk DH, Wu SY, Huang WS & Reviczky A. Metabolism of sulfoconjugated thyroid hormone derivatives in developing sheep. American Journal of Physiology 1994 266 E892-E896.
4. Wu SY, Huang WS, Polk D, Florsheim WH, Green WL & Fisher DA. Identification of thyroxine-sulfate (T4S) in human serum and amniotic fluid by a novel T4S radioimmunoassay. Thyroid 1992 2 101-105.
5. Wu SY, Polk DH, Chen WL, Fisher DA, Huang WS & Yee B. A 3,3′-Diiodothyronine sulfate cross-reactive compound in serum from pregnant women. Journal of Clinical Endocrinology and Metabolism 1994 78 1505-1508.
6. Wu SY, Fisher DA, Huang WS, Beck-Peccoz P, Emerson CH, Kuo SW et al. Urinary compound W in pregnant women is a potential marker for fetal thyroid function. American Journal of Obstetrics and Gynecologyy 1998 178 886-897.
7. Fisher DA & Klein AH. Thyroid development and disorders of thyroid function in the newborn. New England Journal of Medicine 1981 304 702-712.
8. Landau H, Sack J, Frucht H, Palti Z, Hochner-Celnikier D & Rosenmann A. Amniotic fluid 3,3′,5′-triiodothyronine in the detection of congenital hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1980 50 799-801.
9. El Zahari MM, Vagenakis AG, Hinerfeld L, Emerson CH & Braverman LE. Maternal thyroid function is the major determinant of amniotic fluid 3,3′,5′-triiodothyronine in the rat. Journal of Clinical Investigation 1981 67 1126-1133.
10. Bachrach LK & Burrow GN. Thyroid function in pregnancy. In Pediatric Thyroidology, pp 1-18. Eds F Delange, DA Fisher & P Malvaux. Basel: Karger, 1985.
11. Emerson CH. Thyroid disease during and after pregnancy. In Werner and Ingbar's The Thyroid, edn 7, pp 1025. Eds LE Braverman & RD Utiger. Philadelphia: Lippincott, 1991.
12. Daffos F, Cappella-Pavlovsky M & Forestier F. A new procedure for fetal blood sampling in utero: preliminary results of fifty three cases. American Journal of Obstetrics and Gynecology 1983 146 985-987.
13. Cheron RG, Kapland MM, Larsen PR, Selenkow HA & Crigler JFJ. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. New England Journal of Medicine 1981 304 525-528.
14. Fuggle PW, Grant DB, Smith I & Murphy G. Intelligence, motor skills and behaviour at 5 years in early-treated congenital hypothyroidism. European Journal of Pediatrics 1991 150 570-574.
15. Nicolini U, Venegoni E, Acaia B, Cortelazzi D & Beck-Peccoz P. Prenatal hypothyroidism: is there more than one option? Prenatal Diagnosis. 1996 16 443-448.
16. Gavin LA, Livermore BM, Cavalieri RR, Hammond ME & Castle JN. Serum concentration, metabolic clearance, and production rate of 3,5,3′-triiodothyroacetic acid in normal and athyreotic man. Journal of Clinical Endocrinology and Metabolism 1980 51 529-534.
17. Takeda T, Suzuki S, Liu RT & DeGroot LJ. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. Journal of Clinical Endocrinology and Metabolism 1995 80 2033-2040.
18. Goslings B, Schwartz HL, Dillman W, Surks MI & Oppenheimer JH. Comparison of the metabolism and distribution of L-triiodothyronine and triiodothyroacetic acid in the rat: a possible explanation of differential hormonal potency. Endocrinology 1976 98 666-671.
19. Beck-Peccoz P, Sartorio A, De Medici C, Grugni G, Morabito F & Faglia G. Dissociated thyromimetic effects of 3,5,3′-triiodothyroacetic acid (TRIAC) at the pituitary and peripheral tissue levels. Journal of Endocrinological Investigation 1981 1 113-118.
20. Pardi G, Cetin I, Marconi AM, Lanfranchi A, Bozzetti P, Ferrazzi E et al. Diagnostic value of blood sampling in fetuses with growth retardation. New England Journal of Medicine 1993 328 692-696.
21. Eelkman-Rooda SJ, Kaptein E, Van Loon MAC & Visser TJ. Development of a radioimmunoassay for triiodothyronine sulfate. Journal of Immunoassay 1988 9 125-134.
22. Mol JA & Visser TJ. Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology 1985 117 1-7.
23. Wu SY, Chopra IJ, Nakamura Y, Soloman DH & Bennel LR. A radioimmunoassay for measurement of 3,3′-L-diiodothyronine (T2). Journal of Clinical Endocrinology and Metabolism 1976 43 682-685.
24. Achiron R, Rotstein Z, Lipitz S, Karasik A & Seidman DS. The development of the foetal thyroid: in utero ultrasonographic measurements. Clinical Endocrinology 1998 48 259-264.
25. Perelman AH, Johnson RL, Clemons RD, Finber HJ, Clewell WH & Trujillo L. Intrauerine diagnosis and treatment of fetal goitrous hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1990 71 618-621
26. Abhamad AZ, Fisher DA, Warsaf SL, Slotnick RN, Pyle PG & Wu SY. Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case report and review of literature. Ultrasound in Obstetrics and Gynecology 1995 6 368-371.
27. Glorieux J, Dussault JH, Marisette J, Desjardins M, Letarte J & Guyda H. Follow-up of ages 5 and 7 years on mental development in children with hypothyroidism detected by Quebec screening program. Journal of Pediatrics 1988 107 913-915.
28. Porterfield SP & Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development - current perspectives. Endocrine Reviews 1993 14 94-106.
29. La Franchi S. Recent developments in pediatric thyroidology. Thyroid Today 1998 21 1-13.
30. Kooistra L, Van der Meere JJ, Vulsma T & Kalverboer AF. Sustained attention problems in children with early congenital hypothyroidism. Acta Pediatrica 1996 85 425-429.
31. Peter F, Muszsnai A & Szigetvari A. Intellectual assessment of hypothyroid children detected by screening. Acta Medica Austriaca 1992 19 60-61.
32. Calaciura F, Mendorla G, Distefano M, Castorina S, Fazio T, Motta RM et al. Childhood IQ measurements in infants with transient congenital hypothyroidism. Clinical Endocrinology 1995 45 473-477.
33. Morreale de Escobar G, Obregòn MJ, Calvo R & Escobar del Rey F. Effects of iodine deficiency on thyroid hormone metabolism and the brain in fetal rats: the role of the maternal transfer of thyroxine. American Journal of Clinical Nutrition 1993 57 (Suppl 2) 280-285.
34. Mortimer RH, Galligan JP, Cannell GR, Addison RS & Roberts MS. Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination. Journal of Clinical Endocrinology and Metabolism 1996 81 2247-2249.
35. Castro MI, Braverman LE, Alex S, Wu CF & Emerson CH. Inner-ring deiodination of 3,5,3′-triiodothyronine in the in situ perfused guinea pig placenta. Journal of Clinical Investigation 1985 76 1921-1926.
36. Vulsma T, Gons MH & De Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect on thyroid agenesis. New England Journal of Medicine 1989 321 13-16.
37. Sack J, Kaiserman I & Siebner R. Maternal-fetal T4 transfer does not suffice to prevent the effect of in utero hypothyroidism. Hormone Research 1993 39 1-7.
38. Fisher DA. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clinical Obstetrics and Gynecology 1997 40 16-31.
39. Van Loon AJ, Derkesen JT, Bos AF & Rouwé CW. In utero diagnosis and treatment of fetal goitrous hypothyroidism, caused by maternal use of propylthiouracil. Prenatal Diagnosis 1995 15 599-604.
40. Asleria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D et al. Prenatal diagnosis of thyroid hormone resistance. Journal of Clinical Endocrinology and Metabolism 1999 84 405-410.
41. Thorpe-Beeston JG, Nicolaides KH, Butler J, Felton CV & McGregor AM. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. New England Journal of Medicine 1991 324 532-536.
42. Calvo R, Obregon MJ, Ruiz de Ona C, Escobar del Rey F & Morreale de Escobar G. Congenital hypothyroidism, as studied in rats. Journal of Clinical Investigation 1990 86 889-899.
43. Wu SY, Polk DH, Fisher DA, Huang WS, Reviczky AL & Chen WL. Identification of 3,3′-diiodothyronine sulfate (3,3′-T2S) as a fetal thyroid hormone derivative in maternal urine in sheep. American Journal of Physiology 1995 268 E33-E39.
44. Beck-Peccoz P, Asteria C & Mannavola D. Resistance to thyroid hormone. In Contemporary Endocrinology: Disease of the Thyroid, pp 199-239. Ed. LE Braverman. Totowa, NJ: Humana Press, 1997.